Biodesix Inc (NAS:BDSX)

$ 1.46 -0.19 (-11.52%) Market Cap: 167.44 Mil Enterprise Value: 237.55 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 55/100

Q1 2024 Biodesix Inc Earnings Call Transcript
May 08, 2024

$1.55

Earnings
Q4 2023 Biodesix Inc Earnings Call Transcript
Mar 01, 2024

$1.58 (+2.60%)

Earnings
Q3 2023 Biodesix Inc Earnings Call Transcript
Nov 07, 2023

$1.48 (+2.07%)

Earnings
Biodesix Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2023
Biodesix Inc at Canaccord Genuity Growth Conference Transcript
Aug 09, 2023
Q2 2023 Biodesix Inc Earnings Call Transcript
Aug 07, 2023

$1.54 (-2.53%)

Earnings
Biodesix Inc at William Blair Growth Stock Conference Transcript
Jun 07, 2023
Q1 2023 Biodesix Inc Earnings Call Transcript
May 11, 2023

$1.71 (+4.27%)

Earnings
Biodesix Inc at Cowen Health Care Conference Transcript
Mar 07, 2023
Q4 2022 Biodesix Inc Earnings Call Transcript
Mar 06, 2023

$1.8 (-10.00%)

Earnings
Q3 2022 Biodesix Inc Earnings Call Transcript
Nov 03, 2022

$1.05 (+2.75%)

Earnings
Biodesix Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022
Biodesix Inc at Canaccord Genuity Growth Conference Transcript
Aug 10, 2022
Q2 2022 Biodesix Inc Earnings Call Transcript
Aug 04, 2022

$2.89 (+4.71%)

Earnings
Biodesix Inc at William Blair Growth Stock Conference Transcript
Jun 08, 2022
Q1 2022 Biodesix Inc Earnings Call Transcript
May 11, 2022

$1.51 (-15.41%)

Earnings
Q4 2021 Biodesix Inc Earnings Call Transcript
Mar 14, 2022

$2.16 (-3.57%)

Earnings
Q3 2021 Biodesix Inc Earnings Call Transcript
Nov 15, 2021

$7.69 (-1.54%)

Earnings
Q2 2021 Biodesix Inc Earnings Call Transcript
Aug 10, 2021

$9.84 (+7.42%)

Earnings
Q1 2021 Biodesix Inc Earnings Call Transcript
May 11, 2021

$14.75 (-1.73%)

Earnings

Biodesix Inc at William Blair Growth Stock Conference Transcript

Jun 08, 2022 / 02:20PM GMT

Release Date Price: $2.03 (+13.41%)

Transcript

Brian Weinstein

William Blair - Group Head, Life Sciences

Thanks. Good morning. Good morning. It's a three for people who are here for half-a-day on Monday, so everybody looks good. I was just told that, for people who are looking for a stiff drink, that after a hard day here, that I shared in across the street is -- had some generous for us last night. It sounds like so.

Well, good morning, everybody. My name is Brian Weinstein. I'm the Group Head of Life Sciences here at William Blair, and I'm responsible for coverage of Biodesix. My broader coverage includes life science tools and diagnostics.

I am required to inform you that for a complete list of research disclosures or potential conflicts of interest, to please visit our website at williamblair.com. It would make my compliance officer, Michael Besenjak, very happy if you did that.

Logistically, the format here is a management presentation, which we expect will take pretty much all 30 minutes. Following this, we will host a 30-minute breakout session located in the Burnham A. room. The breakout will be a fireside chat.

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.